(Mark One) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
France | 98-0667516 | |||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
300 East Lombard Street, Suite 1710 | ||||||
Baltimore, | MD | |||||
21202 | ||||||
(Zip Code) | ||||||
(Address of principal executive office (US)) | ||||||
(443) | 420-7861 | |||||
(Registrant's telephone number, including area code) | ||||||
Securities registered pursuant to section 12(b) of the Act | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
Ordinary Shares | CSTM | New York Stock Exchange | ||||
Large accelerated filer | ☑ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |
Emerging growth company | ☐ |
Page | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 1. | |||
Item 1A. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 5. | |||
Item 6. | |||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Revenue | 2 | 2,461 | 1,979 | |||
Cost of sales (excluding depreciation and amortization) | (2,041) | (1,716) | ||||
Depreciation and amortization | (83) | (78) | ||||
Selling and administrative expenses | (97) | (78) | ||||
Research and development expenses | (13) | (13) | ||||
Other gains and losses – net | 4 | 73 | (5) | |||
Finance costs – net | 5 | (28) | (27) | |||
Income before tax | 272 | 62 | ||||
Income tax expense | 6 | (76) | (24) | |||
Net income | 196 | 38 | ||||
Attributable to: | ||||||
Equity holders of Constellium | 199 | 37 | ||||
Non-controlling interests | (3) | 1 | ||||
Net income | 196 | 38 | ||||
Earnings per share attributable to the equity holders of Constellium (in U.S. dollars) | Notes | |||||
Basic | 7 | 1.47 | 0.26 | |||
Diluted | 7 | 1.42 | 0.26 |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Net income | 196 | 38 | ||||
Other comprehensive (loss) / income | ||||||
Net change in post-employment benefit obligations | (5) | (3) | ||||
Income tax on net change in post-employment benefit obligations | 1 | 1 | ||||
Net change in cash flow hedges | 12 | (8) | 12 | |||
Income tax on cash flow hedges | 2 | (3) | ||||
Currency translation adjustments | (5) | 4 | ||||
Other comprehensive (loss) / income | (15) | 11 | ||||
Total comprehensive income | 181 | 49 | ||||
Attributable to: | ||||||
Equity holders of Constellium | 184 | 48 | ||||
Non-controlling interests | (3) | 1 | ||||
Total comprehensive income | 181 | 49 | ||||
(in millions of U.S. dollars) except share data and as otherwise stated | Notes | At March 31, 2026 | At December 31, 2025 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | 143 | 120 | ||||
Trade receivables and other, net | 8 | 1,005 | 723 | |||
Inventories | 9 | 1,671 | 1,407 | |||
Fair value of derivatives instruments and other financial assets | 132 | 72 | ||||
Total current assets | 2,951 | 2,322 | ||||
Non-current assets | ||||||
Property, plant and equipment, net | 2,524 | 2,585 | ||||
Goodwill | 47 | 47 | ||||
Intangible assets, net | 84 | 88 | ||||
Deferred tax assets | 202 | 270 | ||||
Trade receivables and other, net | 8 | 33 | 31 | |||
Fair value of derivatives instruments | 12 | 4 | 11 | |||
Total non-current assets | 2,894 | 3,032 | ||||
Total assets | 5,845 | 5,354 | ||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 10 | 1,973 | 1,674 | |||
Current portion of long-term debt | 11 | 35 | 39 | |||
Fair value of derivatives instruments | 12 | 37 | 18 | |||
Income tax payable | 20 | 18 | ||||
Pension and other benefit obligations | 23 | 24 | ||||
Provisions | 14 | 30 | 25 | |||
Total current liabilities | 2,118 | 1,798 | ||||
Non-current liabilities | ||||||
Trade payables and other | 10 | 158 | 163 | |||
Long-term debt | 11 | 1,938 | 1,905 | |||
Fair value of derivatives instruments | 12 | 3 | 3 | |||
Pension and other benefit obligations | 329 | 338 | ||||
Provisions | 14 | 101 | 106 | |||
Deferred tax liabilities | 66 | 70 | ||||
Total non-current liabilities | 2,595 | 2,585 | ||||
Total liabilities | 4,713 | 4,383 | ||||
Commitments and contingencies | 14 | |||||
Shareholders' equity | ||||||
Ordinary shares, par value €0.02, 146,819,884 shares issued at March 31, 2026 and at December 31,2025; 136,150,450 and 135,424,702 shares outstanding at March 31, 2026 and at December 31,2025, respectively | 4 | 4 | ||||
Additional paid in capital | 704 | 693 | ||||
Accumulated other comprehensive income | 15 | 39 | 54 | |||
Retained earnings | 529 | 354 | ||||
Treasury shares 10,669,434 at March 31, 2026 and 11,395,182at December 31, 2025 | (157) | (153) | ||||
Equity attributable to equity holders of Constellium | 1,119 | 952 | ||||
Non-controlling interests | 13 | 19 | ||||
Total equity | 1,132 | 971 | ||||
Total equity and liabilities | 5,845 | 5,354 |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2026 | 135,424,702 | 4 | (153) | 54 | 693 | 354 | 19 | 971 | ||||||||
Net income | — | — | — | — | — | 199 | (3) | 196 | ||||||||
Other comprehensive loss | — | — | — | (15) | — | — | — | (15) | ||||||||
Total comprehensive (loss) / income | — | — | — | (15) | — | 199 | (3) | 181 | ||||||||
Share issuance | — | — | — | — | — | — | — | — | ||||||||
Share-based compensation | — | — | — | — | 11 | — | — | 11 | ||||||||
Repurchase of ordinary shares | (1,152,075) | — | (28) | — | — | — | — | (28) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | 1,877,823 | — | 24 | — | — | (24) | — | — | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (3) | (3) | ||||||||
At March 31, 2026 | 136,150,450 | 4 | (157) | 39 | 704 | 529 | 13 | 1,132 | ||||||||
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2025 | 143,523,308 | 4 | (51) | (14) | 674 | 93 | 21 | 727 | ||||||||
Net income | — | — | — | — | — | 37 | 1 | 38 | ||||||||
Other comprehensive income | — | — | — | 11 | — | — | — | 11 | ||||||||
Total comprehensive income | — | — | — | 11 | — | 37 | 1 | 49 | ||||||||
Share-based compensation | — | — | — | — | 6 | — | — | 6 | ||||||||
Repurchase of ordinary shares | (1,421,058) | — | (15) | — | — | — | — | (15) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | 815,749 | — | 12 | — | — | (12) | — | — | ||||||||
Other | — | — | — | 2 | — | (2) | — | — | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (2) | (2) | ||||||||
At March 31, 2025 | 142,917,999 | 4 | (54) | (1) | 680 | 116 | 20 | 765 |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Net income | 196 | 38 | ||||
Adjustments | ||||||
Depreciation and amortization | 3 | 83 | 78 | |||
Impairment of assets | 3 | 4 | — | |||
Pension and other long-term benefits | 2 | 2 | ||||
Finance costs - net | 5 | 28 | 27 | |||
Income tax expense | 76 | 24 | ||||
Unrealized (gains) /losses on derivatives - net and from remeasurement of monetary assets and liabilities - net | (43) | 11 | ||||
Other - net | 18 | 11 | ||||
Changes in working capital | ||||||
Inventories | (279) | (69) | ||||
Trade receivables | (249) | (273) | ||||
Trade payables | 326 | 279 | ||||
Other | (36) | (18) | ||||
Change in provisions | 2 | (1) | ||||
Pension and other long-term benefits paid | (14) | (13) | ||||
Interest paid | (29) | (29) | ||||
Income tax paid | (12) | (9) | ||||
Net cash flows from operating activities | 73 | 58 | ||||
Purchases of property, plant and equipment | 3 | (72) | (69) | |||
Property, plant and equipment inflows | 3 | 4 | 8 | |||
Collection of deferred purchase price receivable | 8 | — | 2 | |||
Net cash flows used in investing activities | (68) | (59) | ||||
Repurchase of ordinary shares | (28) | (15) | ||||
Repayments of long-term debt | (1) | (1) | ||||
Net change in revolving credit facilities and short-term debt | 50 | 5 | ||||
Finance lease repayments | (2) | (2) | ||||
Transactions with non-controlling interests | (4) | (2) | ||||
Other financing activities | 5 | (11) | ||||
Net cash flows from / (used in) financing activities | 20 | (26) | ||||
Net increase / (decrease) in cash and cash equivalents | 25 | (27) | ||||
Cash and cash equivalents - beginning of year | 120 | 141 | ||||
Net increase / (decrease) in cash and cash equivalents | 25 | (27) | ||||
Effect of exchange rate changes on cash and cash equivalents | (2) | 4 | ||||
Cash and cash equivalents - end of period | 143 | 118 | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Aerospace rolled products | 329 | 267 | ||
Transportation, industry, defense and other rolled products | 255 | 168 | ||
Packaging rolled products | 1,046 | 868 | ||
Automotive rolled products | 403 | 291 | ||
Specialty and other thin-rolled products | 25 | 24 | ||
Automotive extruded products | 262 | 234 | ||
Other extruded products | 141 | 127 | ||
Total revenue | 2,461 | 1,979 | ||
Three months ended March 31, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | 609 | 1,477 | 415 | 2 | 468 | 1,187 | 381 | — | ||
Inter-segment elimination | (26) | (3) | (13) | — | (33) | (3) | (21) | — | ||
External revenue | 583 | 1,474 | 402 | 2 | 435 | 1,184 | 360 | — | ||
Cost of metal | (280) | (1,039) | (236) | 2 | (185) | (859) | (214) | 2 | ||
Production costs | (174) | (254) | (117) | (2) | (146) | (239) | (107) | (2) | ||
Other segment expenses (A) | (27) | (30) | (25) | (17) | (22) | (26) | (23) | (11) | ||
Segment Adjusted EBITDA | 102 | 151 | 24 | (15) | 82 | 60 | 16 | (11) | ||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
A&T | 102 | 82 | ||||
P&ARP | 151 | 60 | ||||
AS&I | 24 | 16 | ||||
H&C (A) | (15) | (11) | ||||
Segment Adjusted EBITDA | 262 | 147 | ||||
Metal price lag (B) | 97 | 39 | ||||
Depreciation and amortization | (83) | (78) | ||||
Impairment of assets | (4) | — | ||||
Share based compensation | 16 | (11) | (6) | |||
Pension and other post-employment benefits - non - operating gains | 3 | 3 | ||||
Restructuring costs | (3) | (1) | ||||
Unrealized gains / (losses) on derivatives | 42 | (12) | ||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 1 | (1) | ||||
Other (C) | — | 3 | ||||
Expenses on factoring arrangements | 8 | (4) | (5) | |||
Finance costs – net | 5 | (28) | (27) | |||
Income before tax | 272 | 62 | ||||
Income tax expense | 6 | (76) | (24) | |||
Net income | 196 | 38 | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
A&T | (10) | (13) | ||
P&ARP | (48) | (34) | ||
AS&I | (10) | (14) | ||
Total capital expenditures (A) | (68) | (61) | ||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
A&T | (18) | (17) | ||
P&ARP | (47) | (44) | ||
AS&I | (20) | (16) | ||
H&C (A) | (2) | (1) | ||
Total depreciation, amortization and impairment expense | (87) | (78) | ||
(in millions of U.S. dollars) | At March 31, 2026 | At December 31, 2025 | ||
A&T | 1,501 | 1,375 | ||
P&ARP | 2,664 | 2,405 | ||
AS&I | 731 | 711 | ||
H&C (A) | 468 | 390 | ||
Deferred income tax assets | 202 | 270 | ||
Cash and cash equivalents | 143 | 120 | ||
Fair value of derivatives instruments and other financial assets | 136 | 83 | ||
Total assets | 5,845 | 5,354 |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Operating income and expenses | ||||||
Realized gains / (losses) on derivatives (A) | 38 | 6 | ||||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net (A) | 12 | 42 | (12) | |||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 1 | (1) | ||||
Impairment of assets | (4) | — | ||||
Restructuring costs | (3) | (1) | ||||
Result from the flood in Valais | 3 | — | 4 | |||
Non-operating income and expenses | ||||||
Expenses on factoring arrangements | 8 | (4) | (5) | |||
Pension and other post-employment benefits | 13 | 3 | 3 | |||
Other | — | 1 | ||||
Total other gains and losses - net | 73 | (5) | ||||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Interest expense on borrowings (A) | (26) | (25) | ||||
Interest cost on pension and other long-term benefits | 13 | (2) | (2) | |||
Realized and unrealized (losses) / gains on debt derivatives at fair value (B) | 12 | 5 | (9) | |||
Realized and unrealized exchange (losses) / gains on financing activities - net (B) | (4) | 10 | ||||
Other finance expenses | (2) | (2) | ||||
Capitalized borrowing costs (C) | 1 | 1 | ||||
Finance expenses | (28) | (27) | ||||
Finance costs - net | (28) | (27) | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars except share and per share amounts ) | 2026 | 2025 | ||
Numerator: | ||||
Net income attributable to equity holders of Constellium | 199 | 37 | ||
Denominator: | ||||
Basic - weighted-average ordinary shares outstanding | 135,394,675 | 142,495,499 | ||
Dilutive effect of non-vested restricted stock units and performance-based restricted stock units | 4,689,980 | 1,594,032 | ||
Diluted - weighted-average ordinary shares, of restricted stock units and performance- based restricted stock units | 140,084,655 | 144,089,531 | ||
Basic earnings per share | $1.47 | $0.26 | ||
Diluted earnings per share | $1.42 | $0.26 | ||
At March 31, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade receivables - gross | 856 | 614 | ||
Allowance for credit losses | (3) | (3) | ||
Total trade receivables - net | 853 | 611 | ||
Total other receivables | 152 | 112 | ||
Total trade receivables and other | 1,005 | 723 |
(in millions of U.S. dollars) | At March 31, 2026 | At December 31, 2025 | ||
Finished goods | 336 | 324 | ||
Work in progress | 789 | 625 | ||
Raw materials | 445 | 356 | ||
Stores and supplies | 101 | 102 | ||
Total inventories | 1,671 | 1,407 |
At March 31, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade payables | 1,529 | 1,222 | ||
Employees' entitlements | 262 | 268 | ||
Other payables | 182 | 184 | ||
Total other | 444 | 452 | ||
Total trade payables and other | 1,973 | 1,674 |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Contract liabilities and other liabilities to customers at January 1, | 113 | 98 | ||
Revenue deferred to contract liabilities | 12 | 13 | ||
Revenue recognized from contract liabilities | (12) | (11) | ||
Effect of changes in foreign currency rates and other changes | (3) | 2 | ||
Contract liabilities and other liabilities to customers at March 31, | 110 | 102 | ||
At March 31, 2026 | At December 31, 2025 | |||||||||
(in millions of U.S. dollars) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) | $50 | Floating | 4.96% | 50 | — | 1 | 51 | — | ||
Senior Unsecured Notes | ||||||||||
Issued June 2020 and due 2028 | $325 | 5.625% | 6.05% | 325 | (2) | 5 | 328 | 323 | ||
Issued February 2021 and due 2029 | $500 | 3.750% | 4.05% | 500 | (3) | 8 | 505 | 500 | ||
Issued June 2021 and due 2029 | €300 | 3.125% | 3.41% | 345 | (3) | 3 | 345 | 355 | ||
Issued August 2024 and due 2032 | $350 | 6.375% | 6.77% | 350 | (5) | 3 | 348 | 353 | ||
Issued August 2024 and due 2032 | €300 | 5.375% | 5.73% | 345 | (5) | 2 | 342 | 354 | ||
Finance lease liabilities | 30 | — | — | 30 | 32 | |||||
Other loans | 25 | — | (1) | 24 | 27 | |||||
Total debt | 1,970 | (18) | 21 | 1,973 | 1,944 | |||||
Of which non-current | 1,938 | 1,905 | ||||||||
Of which current (A) | 35 | 39 | ||||||||
At March 31, 2026 | At December 31, 2025 | |||||||||||
(in millions of U.S. dollars) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 2 | 2 | 4 | 7 | 6 | 13 | ||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 1 | 5 | 6 | 3 | 7 | 10 | ||||||
Currency net debt derivatives | — | 1 | 1 | — | — | — | ||||||
Energy derivatives | 1 | 1 | 2 | 1 | 1 | 2 | ||||||
Metal derivatives | — | 123 | 123 | — | 58 | 58 | ||||||
Fair value of derivatives instruments - assets | 4 | 132 | 136 | 11 | 72 | 83 | ||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 1 | 10 | 11 | 1 | 4 | 5 | ||||||
Energy derivatives | 2 | 3 | 5 | 1 | 2 | 3 | ||||||
Metal derivatives | — | 24 | 24 | 1 | 12 | 13 | ||||||
Fair value of derivatives instruments - liabilities | 3 | 37 | 40 | 3 | 18 | 21 | ||||||
At March 31, 2026 | At December 31, 2025 | |||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivatives instruments - assets | 69 | 67 | — | 136 | 32 | 51 | — | 83 | ||||||||
Fair value of derivatives instruments - liabilities | 15 | 25 | — | 40 | 5 | 16 | — | 21 | ||||||||
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2026-2031 | 522 | 273 | |||
CHF | 2026-2029 | 57 | 10 | |||
CZK | 2026 | 2 | — | |||
Other currencies | 2026-2027 | 8 | — |
Purchased currencies | ||||||
USD | 2026-2027 | 118 | 11 | |||
CHF | 2026-2028 | 148 | 19 | |||
CZK | 2026-2027 | 83 | 11 | |||
Other currencies | 2026 | 9 | — |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Other gains and losses - net | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | 1 | (3) | ||
Unrealized (losses) / gains on foreign currency derivatives - net (B) | (12) | 15 | ||
Derivatives that qualify for hedge accounting | ||||
Included in Other comprehensive income | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | (7) | 11 | ||
(Losses) / gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | (1) | 1 | ||
Included in Revenue (C) | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | 2 | (3) | ||
Unrealized gains on foreign currency derivatives - net | — | 2 | ||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Finance costs - net | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | 5 | (9) | ||
Unrealized gains / (losses) on foreign currency derivatives - net | — | — | ||
Total | 5 | (9) | ||
(in millions of U.S. dollars) | Maturity Year | Less than 1 year | Over 1 year | |||
Metal | 2026-2028 | 417 | (1) | |||
Natural gas | 2026-2028 | 27 | 27 |
Three months ended March 31, | ||||
(in millions of U.S. dollar) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Other gains and losses - net | ||||
Realized gains / (losses) on commodities derivatives - net (A) | 37 | 9 | ||
Unrealized gains / (losses) on commodities derivatives - net | 54 | (27) | ||
Three months ended March 31, | |||||||
2026 | 2025 | ||||||
(in millions of U.S. dollars) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | |||
Current service cost | (4) | (1) | (4) | (1) | |||
Interest cost | (6) | (2) | (6) | (2) | |||
Expected return on plan assets | 6 | — | 6 | — | |||
Amortization of past service gain | — | 3 | — | 3 | |||
Total net pension and other long-term benefit cost | (4) | — | (4) | — | |||
At March 31, 2026 | At December 31, 2025 | |||||||
(in millions of U.S. dollars) | Current | Non-current | Current | Non-current | ||||
Close down and environmental remediation costs | 14 | 82 | 13 | 85 | ||||
Restructuring costs | 2 | 1 | 1 | — | ||||
Legal claims and other costs | 14 | 18 | 11 | 21 | ||||
Total provisions | 30 | 101 | 25 | 106 | ||||
Three months ended March 31, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2026 | 115 | 8 | (69) | 54 | ||||
Other comprehensive income / (loss) before reclassification | (1) | (5) | (5) | (11) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (3) | (1) | — | (4) | ||||
At March 31, 2026 | 111 | 2 | (74) | 39 | ||||
Three months ended March 31, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2025 | 84 | (14) | (84) | (14) | ||||
Other comprehensive income / (loss) before reclassification | — | 8 | 4 | 12 | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (2) | 1 | — | (1) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | — | — | 2 | 2 | ||||
At March 31, 2025 | 82 | (5) | (78) | (1) | ||||
2026 PSUs | ||
Fair value at grant date (in dollars) | 34.38 | |
Share price at grant date (in dollars) | 24.59 | |
Dividend yield | — | |
Expected volatility (A) | 46% | |
Risk-free interest rate (US government bond yield) | 3.75% |
Three months ended March 31, 2026 | ||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | ||
A&T | 25% | 39% | ||
P&ARP | 60% | 58% | ||
AS&I | 17% | 9% | ||
H&C (1) | —% | (6)% | ||
Total | 100% | 100% | ||
Three months ended March 31, | Percent changes QTD | |||||
(U.S. dollars per ton) | 2026 | 2025 | 2026 vs 2025 | |||
Average LME transaction price | 3,199 | 2,627 | 22% | |||
Average Midwest premium | 2,296 | 712 | 222% | |||
Average all-in aluminum price U.S. | 5,495 | 3,339 | 65% | |||
Average LME transaction price | 3,199 | 2,627 | 22% | |||
Average Rotterdam premium | 392 | 290 | 35% | |||
Average all-in aluminum price Europe | 3,591 | 2,917 | 23% | |||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
Revenue | 2,461 | 100% | 1,979 | 100% | ||||
Cost of sales (excluding depreciation and amortization) | (2,041) | 83% | (1,716) | 87% | ||||
Depreciation and amortization | (83) | 3% | (78) | 4% | ||||
Selling and administrative expenses | (97) | 4% | (78) | 4% | ||||
Research and development expenses | (13) | 1% | (13) | 1% | ||||
Other gains and losses – net | 73 | 3% | (5) | —% | ||||
Finance costs – net | (28) | 1% | (27) | 1% | ||||
Income before tax | 272 | 11% | 62 | 3% | ||||
Income tax expense | (76) | 3% | (24) | 1% | ||||
Net income | 196 | 8% | 38 | 2% | ||||
Shipment volumes (in kt) | 370 | n/a | 372 | n/a | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Realized gains / (losses) on foreign currency derivatives - net | 1 | (3) | ||
Realized gains on commodities derivatives - net | 37 | 9 | ||
Realized gains / (losses) on derivatives | 38 | 6 | ||
Unrealized (losses) / gains on foreign currency derivatives - net | (12) | 15 | ||
Unrealized gains / (losses) on commodities derivatives - net | 54 | (27) | ||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net | 42 | (12) | ||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
A&T | 609 | 25% | 468 | 24% | ||||
P&ARP | 1,477 | 60% | 1,187 | 60% | ||||
AS&I | 415 | 17% | 381 | 19% | ||||
H&C (1) | 2 | —% | — | —% | ||||
Inter-segment eliminations | (42) | n.m | (57) | n.m | ||||
Total revenue | 2,461 | 100% | 1,979 | 100% | ||||
Three months ended March 31, | ||||||||
(in kt and as a % of shipments) | 2026 | 2025 | ||||||
A&T | 60 | 16% | 51 | 14% | ||||
P&ARP | 261 | 71% | 269 | 72% | ||||
AS&I | 51 | 14% | 52 | 14% | ||||
Inter-segment eliminations | (2) | n.m | — | n.m | ||||
Total shipments | 370 | 100% | 372 | 100% | ||||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
A&T | 102 | 17% | 82 | 18% | ||||
P&ARP | 151 | 10% | 60 | 5% | ||||
AS&I | 24 | 6% | 16 | 4% | ||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the three months ended March 31, 2025 | 82 | 60 | 16 | |||
Volume | 32 | (6) | (4) | |||
Price and product mix | (2) | 26 | (2) | |||
Costs | (16) | 65 | 11 | |||
Foreign exchange and other | 6 | 6 | 3 | |||
Segment Adjusted EBITDA for the three months ended March 31, 2026 | 102 | 151 | 24 |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net Cash Flows from / (used in) | ||||
Operating activities | 73 | 58 | ||
Investing activities | (68) | (59) | ||
Financing activities | 20 | (26) | ||
Net (decrease) / increase in cash and cash equivalents, excluding the effect of exchange rate changes | 25 | (27) | ||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net income | 196 | 38 | ||
Income tax expense | 76 | 24 | ||
Finance costs – net | 28 | 27 | ||
Expenses on factoring arrangements | 4 | 5 | ||
Depreciation and amortization | 83 | 78 | ||
Restructuring costs | 3 | 1 | ||
Unrealized gains on derivatives | (42) | 12 | ||
Unrealized exchange gains from the remeasurement of monetary assets and liabilities – net | (1) | 1 | ||
Pension and other post-employment benefits - non - operating gains | (3) | (3) | ||
Share based compensation | 11 | 6 | ||
Gains / (losses) on disposal | — | — | ||
Other (A) | — | (3) | ||
Adjusted EBITDA1 | 359 | 186 | ||
of which Metal price lag (B) | 97 | 39 | ||
Period | Total number of shares purchased | Average price paid per share (in U.S. dollars) | Total number of shares purchased as part of publicly announced plans or programs | Maximum approximate dollar value of shares that may yet be purchased under the program | ||||
January 1 - January 31, 2026 | 354,931 | 20.48 | 354,931 | 98,851,993 | ||||
February 1 - February 28, 2026 | 509 | 21.99 | 509 | 98,840,801 | ||||
March 1 - March 31, 2026 | 796,635 | 25.10 | 796,635 | 78,841,643 | ||||
Total | 1,152,075 | 1,152,075 | 78,841,643 |
Exhibit | Description |
10.1 | |
10.2 | |
10.3 | |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | |||
Date: | April 29, 2026 | By: | /s/ Ingrid Joerg |
Name: Ingrid Joerg | |||
Title: Chief Executive Officer and Director | |||
Date: | April 29, 2026 | By: | /s/ Jack Guo |
Name: Jack Guo | |||
Title: Executive Vice President & Chief Financial Officer |